drugset / Trial / NCT04327063

MIRs 04 : Interpectoral Nerve Block With Ropivacaine Versus Placebo Before Breast Cancer Surgery

NCT04327063 ↗

Phase 3 Completed 182 enrolled Institut Curie
RandomizedParallel-groupDouble-blindTreatment

Summary

Compare the effect of ropivacaine versus placebo pectoral nerve block (Pecs 1 and 2) on acute pain after tumorectomy plus sentinel lymph node dissection on one day surgery.

Timeline

Start
2020-08-04
Primary completion
2021-12-30
Completion
2022-01-28

Outcome

Met primary endpoint

paper The analgesic rescue incidence was lower in the ropivacaine group. PMID 40068583 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 5 mg/ml Other

Indications